Cost-effectiveness of maintenance treatment with a barrier-strengthening moisturizing cream in patients with atopic dermatitis in Finland, Norway and Sweden
(2016) In Acta Dermato-Venereologica 96(2). p.173-176- Abstract
- Atopic dermatitis is a chronic skin disorder with high prevalence, especially in the Nordic countries. Effective maintenance therapy during symptom-free episodes may prolong the time to eczema relapse according to a previously published clinical trial. The present study evaluates the cost-effectiveness of a barrier-strengthening moisturizer containing 5% urea, compared with a moisturizer with no active ingredients during eczema-free periods. A health economic microsimulation model, based on efficacy data from a randomized clinical trial, analysed the cost-effectiveness of the barrier-strengthening treatment in Finland, Norway and Sweden. The barrier-strengthening moisturizer was cost-saving compared with the moisturizer with no active... (More)
- Atopic dermatitis is a chronic skin disorder with high prevalence, especially in the Nordic countries. Effective maintenance therapy during symptom-free episodes may prolong the time to eczema relapse according to a previously published clinical trial. The present study evaluates the cost-effectiveness of a barrier-strengthening moisturizer containing 5% urea, compared with a moisturizer with no active ingredients during eczema-free periods. A health economic microsimulation model, based on efficacy data from a randomized clinical trial, analysed the cost-effectiveness of the barrier-strengthening treatment in Finland, Norway and Sweden. The barrier-strengthening moisturizer was cost-saving compared with the moisturizer with no active ingredients in all 3 countries. The result was confirmed in all but 1 sensitivity analysis. In conclusion, the barrier-strengthening moisturizer is cost-effective as maintenance therapy for patients with atopic dermatitis compared with a moisturizer with no active ingredients. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7834941
- author
- Norrlid, Hanna ; Hjalte, Frida ; Lundqvist, Adam ; Svensson, Åke LU and Ragnarson Tennvall, Gunnel LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Dermato-Venereologica
- volume
- 96
- issue
- 2
- pages
- 173 - 176
- publisher
- Medical Journals Limited
- external identifiers
-
- pmid:26304099
- scopus:84954472309
- wos:000373943700005
- pmid:26304099
- ISSN
- 1651-2057
- DOI
- 10.2340/00015555-2221
- language
- English
- LU publication?
- yes
- id
- d3c75c79-974b-4cca-aa6a-330e77cc4402 (old id 7834941)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26304099?dopt=Abstract
- date added to LUP
- 2016-04-01 13:11:41
- date last changed
- 2022-03-13 22:45:28
@article{d3c75c79-974b-4cca-aa6a-330e77cc4402, abstract = {{Atopic dermatitis is a chronic skin disorder with high prevalence, especially in the Nordic countries. Effective maintenance therapy during symptom-free episodes may prolong the time to eczema relapse according to a previously published clinical trial. The present study evaluates the cost-effectiveness of a barrier-strengthening moisturizer containing 5% urea, compared with a moisturizer with no active ingredients during eczema-free periods. A health economic microsimulation model, based on efficacy data from a randomized clinical trial, analysed the cost-effectiveness of the barrier-strengthening treatment in Finland, Norway and Sweden. The barrier-strengthening moisturizer was cost-saving compared with the moisturizer with no active ingredients in all 3 countries. The result was confirmed in all but 1 sensitivity analysis. In conclusion, the barrier-strengthening moisturizer is cost-effective as maintenance therapy for patients with atopic dermatitis compared with a moisturizer with no active ingredients.}}, author = {{Norrlid, Hanna and Hjalte, Frida and Lundqvist, Adam and Svensson, Åke and Ragnarson Tennvall, Gunnel}}, issn = {{1651-2057}}, language = {{eng}}, number = {{2}}, pages = {{173--176}}, publisher = {{Medical Journals Limited}}, series = {{Acta Dermato-Venereologica}}, title = {{Cost-effectiveness of maintenance treatment with a barrier-strengthening moisturizing cream in patients with atopic dermatitis in Finland, Norway and Sweden}}, url = {{https://lup.lub.lu.se/search/files/3215078/8618415}}, doi = {{10.2340/00015555-2221}}, volume = {{96}}, year = {{2016}}, }